Trademark: RESVERASYN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for RESVERASYN
We do not have any records of a proof of use for RESVERASYN at this moment.
Possible trademark infringements of RESVERASYN
Basic Information about RESVERASYN
- Serial Number
- 90872475
- Filing Date
- 09 Aug 2021
- Registration Number
- 6971236
- Registration Date
- 07 Feb 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of RESVERASYN on the blockchain with WikiTrademarks.io.
- First use of RESVERASYN anywhere
- RESVERASYN was first used on 01 Oct 2011 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns RESVERASYN?
1. Biological Prospects, LLC Lexington KY
2. Biological Prospects, LLC Lexington KY
3. Biological Prospects, LLC Lexington KY
Correspondent
- Joseph A. Sebolt
- Sand, Sebolt & Wernow Co., LPA
- Aegis Tower, Suite 1100
- 4940 Munson St. NW
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io